StockNews.com Upgrades Puma Biotechnology (NASDAQ:PBYI) to Strong-Buy
StockNews.com upgraded shares of Puma Biotechnology (NASDAQ:PBYI – Free Report) from a buy rating to a strong-buy rating in a research note released on Friday morning. Separately, HC Wainwright restated a “buy” rating and issued a $7.00 price objective on shares of Puma Biotechnology in a research note on Friday. Get Our Latest Analysis on […]
